Business Summary

• Current cancer panel tests lead to new treatments in only about 10% of cases, so that further performance improvement is required to expand treatment opportunities and achieve precision medicine.
• Histopathology images and protein expression information (immunohistochemistry) are currently used independently, but artificial intelligence technology will be utilized to quantify complex and abstract pathology images, making panel testing multiome.

Contents

• In this project, the following three research and development items will be carried out to realize the refinement of cancer genome medicine through the development of the multiome analysis panel test.
  • Development of a tumor classification method based on gene expression information.
  • Mechanism elucidation and patient stratification using spatial omics information and artificial intelligence.
  • Development of the multiome analysis panel.